Life sciences companies at risk of falling behind technology competitors in race to address evolving consumer demands
- New EY report looks at effect of consumerism and affordability on the life sciences industry
- More than 75% of life sciences Fortune 500 companies may fall out of ranking by 2023, due to increasing competition and industry convergence
- The ability to unlock the power of data by connecting, combining and sharing it will be essential for future value creation
Access the full report here.